A. Harmsze

发表

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.

V. Deneer, J. T. ten Berg, B. Rensing, 2010, JAMA.

Systematic review of drug effects in humans and models with surfactant-processing disease

J. Grutters, A. Harmsze, C. van Moorsel, 2018, European Respiratory Review.

High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention

J. T. ten Berg, J. Kelder, H. Bouman, 2011, Heart.

Resistance of aspirin during and after pregnancy: A longitudinal cohort study.

A. Thijs, M. D. De Boer, A. Harmsze, 2019, Pregnancy hypertension.

Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy.

J. D. de Vries, A. Thijs, M. D. De Boer, 2017, European journal of obstetrics, gynecology, and reproductive biology.

Effect of gender difference on platelet reactivity

F. Zijlstra, M. Sluman, J. M. Berg, 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting

A. de Boer, O. Klungel, V. Deneer, 2012, Pharmacogenetics and genomics.

Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report.

A. Harmsze, Sjoerd de Hoogd, D. Wong, 2019, European journal of gastroenterology & hepatology.

Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C19*2 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

P. Souverein, A. de Boer, V. Deneer, 2011, Journal of thrombosis and haemostasis : JTH.

Increased frequency of CYP2C19 loss‐of‐function alleles in clopidogrel‐treated patients with recurrent cerebral ischemia

P. Hilkens, A. Harmsze, L. S. Otten, 2022, British journal of clinical pharmacology.

Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients

A. de Boer, O. Klungel, V. Deneer, 2011, Platelets.

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.

A. de Boer, V. Deneer, J. T. ten Berg, 2011, Pharmacogenomics.

The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence

J. T. ten Berg, H. Bouman, J. V. van Werkum, 2008, Platelets.

Esomeprazole but Not Pantoprazole is Associated with Lower Plasma Concentrations of Clopidogrel's Active Metabolite

V. Deneer, J. V. van Werkum, A. Harmsze, 2011, The Annals of pharmacotherapy.

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions

M. Söhne, A. Harmsze, M. V. D. van den Broek, 2020, British journal of clinical pharmacology.

Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation

A. de Boer, O. Klungel, V. Deneer, 2010, Pharmacogenetics and genomics.

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

T. Bergmeijer, V. Deneer, J. T. ten Berg, 2011, Heart.

Review of global regulations concerning biowaivers for immediate release solid oral dosage forms.

D. Barends, R. A. Lipper, V. Shah, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study.

V. Deneer, R. Tupker, A. Harmsze, 2008, Acta dermato-venereologica.

Oxybutynin therapy for generalized hyperhidrosis.

V. Deneer, R. Tupker, A. Harmsze, 2006, Archives of dermatology.

Subdivision of aspirin tablets? Use your hands: a study on aspirin tablet subdivision using four different methods

A. Thijs, A. Harmsze, W. Fuijkschot, 2018 .

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

A. de Boer, O. Klungel, V. Deneer, 2010, European heart journal.

The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study.

M. Oudijk, A. Thijs, A. Harmsze, 2022, European journal of obstetrics, gynecology, and reproductive biology.

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study

P. M. van den Bemt, K. Meijer, A. Harmsze, 2021, European Journal of Clinical Pharmacology.

Clomipramine Toxicity in a CYP 2D6 Poor Metabolizer Patient Who Suddenly Stopped Smoking.

I. Drubbel, A. Harmsze, C. de Jong, 2018, Journal of clinical psychopharmacology.

The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response

O. Klungel, V. Deneer, J. T. ten Berg, 2010, Thrombosis and Haemostasis.

Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity

E. V. van Puijenbroek, A. Bast, M. Drent, 2021, Drug Safety.

Effect of oxybutynin on exercise‐induced sweating in healthy individuals

V. Deneer, R. Tupker, A. Harmsze, 2008, The Journal of dermatological treatment.

Patient's estimation of efficacy of various hyperhidrosis treatments in a dermatological clinic.

R. Tupker, A. Harmsze, M. Amini, 2008, Acta dermato-venereologica.

Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation

A. de Boer, O. Klungel, V. Deneer, 2010, Pharmacogenetics and genomics.

Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study.

V. Deneer, R. Tupker, A. Harmsze, 2008, Acta dermato-venereologica.

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

A. de Boer, O. Klungel, V. Deneer, 2010, European heart journal.

CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.

A. de Boer, V. Deneer, J. T. ten Berg, 2011, Pharmacogenomics.

Prolonged coma due to amitriptyline overdose and genetic polymorphism: a case report

P. Bruins, A. Harmsze, A. D. V. de Vries Schultink, 2022, Journal of Medical Case Reports.

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

J. Peper, J. T. ten Berg, N. V. D. van der Sangen, 2024, JACC. Cardiovascular interventions.

[Interaction between clopidogrel and proton pump inhibitors].

P. Mol, A. de Boer, F. Verheugt, 2011, Nederlands tijdschrift voor geneeskunde.